Incremental Costs in Giant Cell Arteritis-Reference-Cited by-同舟云学术

Incremental Costs in Giant Cell Arteritis

Published:2018-04-23 Issue:7 Volume:70 Page:1074-1081
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Mounié Michael¹,Costa Nadège²,Sailler Laurent³,Lapeyre-Mestre Maryse⁴,Bourrel Robert⁵,Savy Nicolas⁶,Molinier Laurent¹,Pugnet Grégory³

Affiliation:

1. Centre Hospitalier Universitaire de Toulouse, UMR 1027 INSERM, and Université de Toulouse; Toulouse France

2. Centre Hospitalier Universitaire de Toulouse, UMR 1027 INSERM; Toulouse France

3. UMR 1027 INSERM, Université de Toulouse, and Service de Médecine Interne, CHU Toulouse; Toulouse France

4. UMR 1027 INSERM, Université de Toulouse, Laboratoire de Pharmacologie Médicale et Clinique, Service de Pharmacologie Clinique, CIC 1436, CHU Toulouse; Toulouse France

5. Caisse Nationale d'Assurance Maladie des Travailleurs Salariés, Service Médical Midi-Pyrénées; Toulouse France

6. Université de Toulouse, and Institut Mathématiques de Toulouse, UMR 5219, CNRS; Toulouse France

Publisher

Wiley

Subject

Rheumatology

Reference49 articles.

1. Polymyalgia rheumatica and giant-cell arteritis;Salvarani;Lancet,2008

2. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study;Gonzalez-Gay;Medicine (Baltimore),2007

3. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients;Gonzalez-Gay;Medicine (Baltimore),2005

4. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes;Proven;Arthritis Rheum,2003

5. Economic note: cost of illness studies;Byford;BMJ,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase-Specific Healthcare Costs Associated With Giant Cell Arteritis in Ontario, Canada;The Journal of Rheumatology;2024-04-01

2. Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis;Expert Opinion on Emerging Drugs;2024-01-02

3. Quality standards for the care of people with giant cell arteritis in secondary care;Rheumatology;2023-01-24

4. Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms;ACR Open Rheumatology;2021-01-25

5. The Delay and Costs of Diagnosing Systemic Vasculitis in a Tertiary-Level Clinic;Rheumatology and Therapy;2020-12-14